Absorption Systems has acquired TGA Sciences, Inc., a contract R&D laboratory located in Medford, MA. TGA Sciences, Inc. will now be TGA Bioservices LLC, a subsidiary of Absorption Systems.  

The acquisition will expand the company’s expertise in research and GxP assay development services, as well as position them closer to customers in the expanding Boston/Cambridge biotech hub. 

Absorption Systems assists pharmaceutical, biotechnology and medical device companies to indentify and overcome Absorption, Distribution, Metabolism, Excretion and Toxicity barriers in the development of drugs, biologics and medical devices.

Patrick Dentinger, president and chief executive officer of Absorption Systems, said, “This deal is a natural fit for both companies, as our areas of combined  expertise  offer a more comprehensive service package to our expanding client base. The newly created subsidiary TGA BioServices is strategically positioned in Boston to respond to both the emerging cell and gene therapy service market and the ever-expanding small molecule market.”